JayMac Pharmaceuticals, LLC Report issue

For profit Phase 4
Founded: Sunset LA United States (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2016
NCT02676882
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

JayMac Pharmaceuticals, LLC